Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mats Ove Johansson is active.

Publication


Featured researches published by Mats Ove Johansson.


International Journal of Pharmaceutics | 1992

In vitro release characteristics of a membrane-coated pellet formulation — influence of drug solubility and particle size

Gert Ragnarsson; Anders Sandberg; Mats Ove Johansson; Bengt Lindstedt; John Sjögren

Abstract The impact of drug solubility and particle size on the in vitro release characteristics of membrane-coated pellets has been investigated for the metoprolol salts, sorbate, benzoate, succinate and fumarate. Three well-defined size fractions of small spherical pellets were prepared for each salt and coated with a membrane of ethylcellulose and hydroxypropyl methylcellulose (proportion 3:1). The particle diameter, surface area, volume and apparent density were determined for each fraction of coated pellets and their drug release properties were characterized by an initial lag-time, a constant release rate phase and a final declining release rate phase. Both the particle size and drug solubility were shown to be important for the release properties of the pellets. Thus, the constant release rate was approximately proportional to the surface area of the pellets over the entire solubility range (~ 20–500 mg/ml). All three phases of the drug release curve were strongly influenced by the drug solubility. This was explained on the basis of the different concentration gradients over the membrane as well as by osmotic effects. Although the release rate was shown to be markedly affected by the osmotic pressure, evaluation of the release kinetics did not reveal osmotic pumping to be the major mechanism for the release. Also, diffusion appears to be important for the drug release from the investigated formulations.


Archive | 1986

Controlled release beads having glass or silicon dioxide core

Lars-Erik David Dahlinder; Mats Ove Johansson; John Anders Sandberg; Sjo


Archive | 1986

New drug preparation with controlled release of the active compound, a method for the manufacture thereof and the use of the new preparation

Lars-Erik David Dahlinder; Mats Ove Johansson; John Anders Sandberg; John Sjögren


Archive | 1986

Controlled release drug preparation

Lars-Erik David Dahlinder; Mats Ove Johansson; John Anders Sandberg; John Sjögren; Ulf Erik Jonsson


Archive | 1988

Process for the preparation of the beads in order to produce a controlled-release products

John Anders Sandberg; John Albert Sjoegren; Lars-Erik David Dahlinder; Mats Ove Johansson


Archive | 1988

Förfarande för framställning av korn för tillverkning av produkter med kontrollerad frisättning

Lars-Erik David Dahlinder; Mats Ove Johansson; John Anders Sandberg; John Albert Sjoegren


Archive | 1987

Nyt laegemiddelpraeparat med kontrolleret frigivelse af den virksomme forbindelse, fremgangsmaade til fremstilling deraf og anvendelse af det nye praeparat

Lars-Erik David Dahlinder; Mats Ove Johansson; John Anders Sandberg; John Albert Sjoegren


Archive | 1987

Nyt lægemiddelpræparat med kontrolleret frigivelse af den virksomme forbindelse, fremgangsmåde til fremstilling deraf

John Anders Sandberg; John Albert Sjoegren; Lars-Erik David Dahlinder; Mats Ove Johansson


Archive | 1987

New drug preparation with controlled release of the active compound, process for its preparation

John Anders Sandberg; John Albert Sjoegren; Lars-Erik David Dahlinder; Mats Ove Johansson


Archive | 1987

New laegemiddelpraeparat controlled release of the active compound, process for their preparation and the use of the new preparation

Lars-Erik David Dahlinder; Mats Ove Johansson; John Anders Sandberg; John Albert Sjoegren

Collaboration


Dive into the Mats Ove Johansson's collaboration.

Researchain Logo
Decentralizing Knowledge